Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 26;7(2):123-134.
doi: 10.26828/cannabis/2024/000223. eCollection 2024.

Using Smartphone Technology to Track Real-Time Changes in Anxiety/Depression Symptomatology Among Florida Cannabis Users

Affiliations

Using Smartphone Technology to Track Real-Time Changes in Anxiety/Depression Symptomatology Among Florida Cannabis Users

R Nathan Pipitone et al. Cannabis. .

Abstract

Objective: Recent scientific attention has focused on the therapeutic effectiveness of cannabis use on a variety of physical and mental ailments. The present study uses smartphone technology to assess self-reported experiences of Florida cannabis users to understand how cannabis may impact anxiety and depression symptomatology.

Method: Several hundred Releaf App™ users from the state of Florida provided anonymous, real-time reports of their symptoms of anxiety and/or depression immediately before and after cannabis use sessions. Linear mixed-effects modeling was used to analyze the data at the symptom and user level.

Results: Results showed that for the majority of users, cannabis use was associated with a significant decrease in depression and anxiety symptomatology. While symptom type, doses per session, consumption method, and CBD levels were significant predictors of relief change, their effect sizes were small and should be interpreted with caution. At the user level, those who had positive relief outcomes in anxiety reported more doses and sessions, and those in the depression group reported more sessions.

Conclusions: Our results generally support the therapeutic effectiveness of cannabis against depression/anxiety symptomatology. Future work should include standardized statistics and effect size estimates for a better understanding of each variable's practical contribution to this area of study.

Keywords: CBD; THC; cannabinoids; medical cannabis; mobile application; mood disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1.
Figure 1.
Average relief for anxiety and depression symptomatology before and after cannabis use sessions for users in the study (N=418). Lines shown above 0 on the y-axis indicate positive relief outcomes (68% and 74% of users respectively). No lines present represent no change in relief (27% and 23% respectively). Lines shown below 0 on the y-axis indicate negative relief outcomes (5% and 3%, respectively).

References

    1. Andrade, A.K., Renda, B., & Murray, J.E. (2019). Cannabinoids, interoception, and anxiety. Pharmacology, Biochemistry, and Behavior, 180, 60–73. 10.1016/j.pbb.2019.03.006 - DOI - PubMed
    1. Ashton, C.H., & Moore, P.B. (2011). Endocannabinoid system dysfunction in mood and related disorders. Act Psychiatrica Scandinavica, 124(4), 251–261. 10.1111/j.1600-0447.2011.01687.x - DOI - PubMed
    1. Bates, D., Mächler, M., Bolker, B., & Walker, S. (2014). Fitting linear mixed-effects models using lme4. arXiv preprint arXiv:1406.5823. 10.48550/arXiv.1406.5823 - DOI
    1. Brody, D. & Qiuping, G. (2020, September 4). Antidepressant use among adults: United States, 2015–2018. NCHS Data Brief, 377. https://www.cdc.gov/nchs/products/databriefs/db377.htm - PubMed
    1. Centers for Disease Control and Prevention (CDC). (2018). National Ambulatory Medical Care Survey: 2018 National Summary Tables. Table 23. https://www.cdc.gov/nchs/data/nhamcs/web_tables/2018-ed-web-tables-508.pdf

LinkOut - more resources